Swedish
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
phospholipid/stroke
Länken sparas på Urklipp
5 resultat
Therapeutic agents for preventing phospholipid degradation and free fatty acid proliferation
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
BACKGROUND OF THE INVENTION
The present invention relates to the use of cytidine diphospho (CDP) compounds as therapeutic agents for preventing phospholipid degradation, and to compositions containing these compounds.
During investigative studies of CDP-choline and CDP-ethanolamine we discovered
Use of lipid conjugates in the treatment of diseases of the nervous system
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
This invention provides a method for treating a subject suffering from a disease or disorder of the nervous system, associated with an inflammatory response. This invention further provides a pharmaceutical composition for treating a subject suffering from a disease of the
Liposome composition containing selegilin
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
This appln. is a 371 of PCT/HU95/00052, filed Oct. 20, 1995.
The invention relates to liposomic compositions containing as active ingredient selegilin (-)-(N-.alpha.-dimethyl-N-(2-propynylphenylethylaniine) and/or a salt thereof. Further, the invention relates to their preparation, pharmaceutical
Use of lipid conjugates in the treatment of diseases
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
This invention provides administrating pharmaceutically active lipid-conjugate compounds directed to treating diseases involving the production of lipid mediators and impairment of glycosaminoglycan (GAG) functioning. This invention provides a method for treating a subject
Use of lipid conjugates in the treatment of disease
Endast registrerade användare kan översätta artiklar
Logga in Bli medlem
FIELD OF THE INVENTION
The present invention provides administrating a class of pharmaceutically active lipid conjugate compounds directed to treating disease, including obstructive respiratory disease, colitis, Crohn's disease, central nervous system insult, multiple sclerosis, contact dermatitis,
Den mest kompletta databasen med medicinska örter som stöds av vetenskapen
- Fungerar på 55 språk
- Växtbaserade botemedel som stöds av vetenskap
- Örter igenkänning av bild
- Interaktiv GPS-karta - märka örter på plats (kommer snart)
- Läs vetenskapliga publikationer relaterade till din sökning
- Sök efter medicinska örter efter deras effekter
- Organisera dina intressen och håll dig uppdaterad med nyheterna, kliniska prövningar och patent
Skriv ett symptom eller en sjukdom och läs om örter som kan hjälpa, skriv en ört och se sjukdomar och symtom den används mot.
* All information baseras på publicerad vetenskaplig forskning
